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TLR-6), cytokines (IL-1b, IL-6, TNF-a) and metalloproteases (MMP-13,
MMP-3 and MMP-9) were determinate in normal, OA rats and OA rats
treated with 100ng/d of 1,25(OH)2D3 (4IU).
Results: TLR-1, TLR-2 and TLR-6 were detected along the progression
of OA but their expression did not differ signiﬁcantly with the control
group. Remarkable, a signiﬁcant increased (p < 0.05; p < 0.0001) of TLR4
mRNA expression was observed since day 8 (2.5 fold) of OA induction.
By immunohistoﬂuorescence, TLR-4 was detected in the superﬁcial and
middle zones of cartilage from day 3 to 20 with highest expression at
day 8. In another hand, a notably level of IL-1b expression (19 fold) was
observed at day 8 of OA induction (p < 0.0001), while TNFa and IL-6
did not show a signiﬁcant difference within the experimental groups.
Among the MMPs, the MMP-3 showed the highest expression at the
8 (2.8 fold; p < 0.05) and 10 (3 fold; p < 0.0001) days of OA. Vitamin D
treatment showed a clear reduction of TLR4, IL-1b and MMP-3 during
the progression (3, 10 and 20 days) of OA.
Conclusions: TLR4 is expressed in rat articular cartilage and it is up
regulated during the induction of OA. Signaling through TLR-4 might
be the pro-inﬂammatory mechanism in osteoarthritis that results in the
expression of IL-1b and MMP-3. Interfering this signaling pathway by
the use of vitamin D reduce the progression of OA in the rat model.
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Purpose: We evaluated the anti-inﬂammatory effect of the combination
of avocado/soybean unsaponiﬁables (ASU), glucosamine (GLU), and
chondroitin sulfate (CS) by measuring production of pro-inﬂammatory
mediators by human articular cartilage. These mediators include
prostaglandin E2 (PGE2), interleukin-6 (IL-6), interleukin-8 (IL-8),
and macrophage chemotactic protein-1 (MCP-1). They are produced
excessively in osteoarthritis (OA) and play critical roles in the
pathogenesis of the disease. These pro-inﬂammatory mediators
participate in the destruction of articular cartilage by inducing enzymes
that degrade extracellular matrix. PGE2 activates cartilage-degrading
enzymes while IL-6 mediates bone resorption. These molecules also
activate inﬂammatory pain pathways. However, at physiologic levels,
these molecules serve multiple functions in cell signaling, proliferation,
tissue repair, and regeneration. Studies have demonstrated that ASU,
GLU, and CS inhibit production of inﬂammatory mediators. They have
been shown to reduce inﬂammation and relieve pain in OA patients
with no adverse effects. These compounds have also been reported as
chondroprotective and exert structure-modifying effects on osteoarthritic
knees. As positive control in our in vitro study, we used aspirin at a
clinically relevant concentration. Aspirin is a widely used non-steroidal
anti-inﬂammatory drug (NSAID) that has recently been cited as causing
gastro-intestinal side effects.
Methods: Human articular cartilage (Articular Engineering Inc.) was cut
into 200mg/well for explant experiments. Explants were pre-incubated
with: (a) control media alone, (b) the combination of ASU (NMX1000®,
8.3mg/ml) + GLU (FCHG49®, 11mg/ml) + CS (TRH122®, 20mg/ml); or (c)
aspirin (100mg/ml) for 24 hrs to seven days. Explants and chondrocytes
were then activated with IL-1b (5 or 10ng/ml) for 24–48 hrs for
measurement of PGE2, IL-6, IL-8, and MCP-1 production by ELISA.
Concentrations of mediators were expressed per mg cartilage wet weight
in explant culture. Data was analyzed by one-way ANOVA, Tukey post-
hoc, with P < 0.05 level of signiﬁcance.
Results: Cartilage explants from normal and OA donors cultured with
control media alone produced undetectable to low levels of PGE2, IL-6,
IL-8, andMCP-1. Activation with IL-1b (5 and 10ng/ml) resulted in similar,
signiﬁcantly increased production of pro-inﬂammatory mediators. These
increases were as much as 80-fold for PGE2, 500-fold for IL-6, 300-
fold for IL-8, and 700-fold for MCP-1 (all P < 0.001). The combination
of ASU+GLU+CS reduced PGE2production down to 10% of IL-1b-activated
levels. The effect of the ASU+GLU+CS combination on the cytokine-
induced production of other mediators was variable. Inhibition was
reduced to 10% of activated levels for IL-6, 40% for IL-8, and 15% for
MCP-1. In contrast, aspirin dramatically reduced production of PGE2
down to 1% of activated levels. Aspirin also decreased IL-6 production
down 10% of activated levels, 38% for IL-8, and 34% for MCP-1.
Conclusion: The present study shows that the combination of
ASU+GLU+CS effectively inhibits cytokine-induced production of PGE2,
IL-6, IL-8, and MCP-1 by cartilage explants. In comparison, aspirin nearly
obliterated the production of PGE2 and reduced the production of IL-6,
IL-8, and MCP-1. This suggests that the combination of ASU+GLU+CS
may have similar mechanisms of action as some NSAIDs such as aspirin.
However, the observation that ASU+GLU+CS attenuated rather than
dramatically suppressed production of PGE2 may help preserve their
physiologic functions. The present study supports the notion that the
ASU+GLU+CS combination may offer an effective anti-inﬂammatory and
chondroprotective approach for the management of OA. The ASU+GLU+CS
combination may help reduce chronic dosing of NSAIDS, thus minimizing
deleterious side effects.
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Purpose: Hereditary Equine Regional Dermal Asthenia (HERDA) is an
autosomal recessive connective tissue disorder resulting in impaired
collagen folding, hyperextensible skin, and abnormal wound repair. We
observed osteoarthritic lesions in tarsal and carpal joints of yearling
HERDA horses. HERDA horses show similarities to the human hereditary
connective tissue syndrome Ehlers-Danlos (EDS). Many EDS patients
suffer from joint pain and osteoarthritis (OA) as adults. The phenotypic
similarities between EDS and HERDA suggest that horses suffering from
HERDA may also develop OA. In OA, excess production of inﬂammatory
mediators activates enzymes that degrade cartilage as well as inhibit
wound healing. These mediators include prostaglandin E2 (PGE2) whose
production is regulated by the cyclooxygenase-2 (COX-2) enzyme, tumor
necrosis factor-a (TNF-a), interleukin-6 (IL-6), and interleukin-8 (IL-8),
The purpose of this study was to characterize articular cartilage from
HERDA afﬂicted horses. We determined the baseline expression of several
pro-inﬂammatory genes and whether their expression could be induced
by the cytokine IL-1b similar to what is observed in OA joints. We
also determined whether induction of these genes could be inhibited by
the combination of avocado/soybean unsaponiﬁables (ASU), glucosamine
(GLU), and chondroitin sulfate (CS). ASU, GLU, and CS are known to inhibit
inﬂammation and are used for the management of OA in both humans
and animals. As a positive control, we used phenylbutazone (PBZ), a
non-steroidal anti-inﬂammatory drug (NSAID) currently used for the
management of both HERDA and equine OA.
Methods: Articular cartilage was harvested from tarsal joints of three
yearling HERDA horses. Chondrocytes were seeded onto 6-well plates
and pre-incubated at 37°C, 5% CO2with: control media alone, PBZ
at a clinically relevant concentration (4mg/mL), or the combination
of ASU (NMX1000®, 8.3mg/mL) + GLU (FCHG49®, 11mg/mL) + CS
(TRH122®, 20mg/mL) for 24 hours. Chondrocytes were activated with
IL-1b (10ng/mL) for 24 hrs. COX-2, IL-6, TNF-a, and IL-8 gene expression
was quantiﬁed by real-time PCR. Pair-wise multiple comparisons were
carried out using one-way ANOVA, Student-Newman-Keuls post-hoc
analysis where differences of P < 0.05 were considered statistically
signiﬁcant.
Results: Chondrocytes incubated with control media alone expressed
low levels of COX-2, IL-6, TNF-a, and IL-8. Cytokine activation induced
a hundred-fold increase (P < 0.001) in the expression of these pro-
inﬂammatory genes. Pre-treatment with ASU+GLU+CS signiﬁcantly
(P < 0.05) decreased COX-2, IL-6, TNF-a, and IL-8 expression by
approximately 30%. In comparison, cytokine-induced increases in COX-2,
IL-6, TNF-a, and IL-8 pro-inﬂammatory gene expression were inhibited
by PBZ by as much as 60% (P < 0.05).
Conclusions: Chondrocytes obtained from horses with HERDA responded
to cytokine stimulation with the up-regulation of several key pro-
inﬂammatory markers that have been associated with the pathogenesis
